Senzime, headquartered in Uppsala, Sweden, leads the global change in perioperative care with its cutting-edge TetraGraph® and ExSpiron® 2Xi monitoring systems, delivering peace of mind and enhanced safety from surgery to recovery. The company’s innovations are designed to eliminate postoperative complications, ensuring the well-being of over 100 million patients globally. With a strong presence across more than 30 countries, Senzime is reshaping standards in healthcare and demonstrating its commitment to precision, empowerment, and swift recovery.
Listed on the Nasdaq Stockholm Main Market (SEZI) and cross-traded on the OTCQX (SNZZF), Senzime is a beacon of progress, merging clinical excellence with shareholder value. Explore how Senzime is pioneering perioperative progress at senzime.com and follow the company on LinkedIn.
- Industries
-
Medical Equipment
- Office Locations
- Uppsala, Sweden; St. Louis, MI, United States
Latest
Journalists and Bloggers
The news you need, when you need it.
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.
LEARN MORE